Status:

COMPLETED

Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen

Lead Sponsor:

Reproductive Medicine Associates of New Jersey

Conditions:

Infertility

Eligibility:

FEMALE

18-42 years

Phase:

NA

Brief Summary

The proposed study is a single-blind randomized controlled trial which seeks to characterize implantation rates following embryo vitrification and subsequent warming with both slush nitrogen and liqui...

Detailed Description

The purpose of this study is to determine if slush nitrogen for embryo vitrification results in higher sustained implantation rates compared to the conventional use of liquid nitrogen. Routine ovarian...

Eligibility Criteria

Inclusion

  • Major Inclusion Criteria for participants:
  • Patients undergoing IVF stimulation cycle with plan for subsequent frozen embryo transfer (FET)
  • Patients electing preimplantation genetic testing for aneuploidy (PGT-A)
  • Couples electing single embryo transfer (SET)
  • Major Exclusion Criteria for participants:
  • All patients who do not voluntarily give their written consent for participation
  • Under 18 years old, above 42 years old
  • BMI \> 35
  • Maximum day 3 Follicle stimulating hormone (FSH) level of 12 or higher
  • Anti-mullerian hormone (AMH) level less than 1.0 g/mL, tested within previous year
  • Total basal antral follicle count less than 6 follicles
  • Failed more than one previous FET cycle
  • Use of oocyte donation
  • Use of gestational carrier
  • Presence of hydrosalpinges that communicate with endometrial cavity
  • Diagnosis of endometrial insufficiency: prior cycle with maximal endometrial thickness ≤ 6mm, abnormal endometrial pattern (failure to attain a trilaminar appearance), persistent endometrial fluid
  • Uncorrected uterine factor infertility (uterine anomaly, submucosal myomas, uterine septum)
  • Single gene disorder chromosomal rearrangement requiring a more detailed embryonic genetic analysis
  • Male partner with \<100,000 total motile spermatozoa per ejaculate (donor sperm is acceptable)
  • Use of surgical procedures to obtain sperm
  • Couples undergoing IVF for fertility preservation with no immediate plan for subsequent FET (embryo banking)
  • Sex selection
  • Personal history of repeated pregnancy loss (two or more unexplained clinical losses defined by presence of fetal heartbeat)

Exclusion

    Key Trial Info

    Start Date :

    September 5 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 20 2022

    Estimated Enrollment :

    253 Patients enrolled

    Trial Details

    Trial ID

    NCT04496284

    Start Date

    September 5 2020

    End Date

    December 20 2022

    Last Update

    May 3 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Reproductive Medicine Assoicates of New Jersey

    Basking Ridge, New Jersey, United States, 07920